SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

111, Inc. – IPO: ‘F-1’ on 8/15/18 – ‘EX-10.11’

On:  Wednesday, 8/15/18, at 2:45pm ET   ·   Accession #:  1047469-18-5629   ·   File #:  333-226849

Previous ‘F-1’:  None   ·   Next:  ‘F-1/A’ on 8/29/18   ·   Latest:  ‘F-1/A’ on 9/7/18   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 8/15/18  111, Inc.                         F-1                   26:7.9M                                   Merrill Corp/New/FA

Initial Public Offering (IPO):  Registration Statement by a Foreign Private Issuer   —   Form F-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-1         Registration Statement by a Foreign Private Issuer  HTML   2.41M 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML    357K 
 3: EX-4.4      Instrument Defining the Rights of Security Holders  HTML    280K 
 4: EX-10.1     Material Contract                                   HTML     15K 
10: EX-10.10    Material Contract                                   HTML     26K 
11: EX-10.11    Material Contract                                   HTML     25K 
12: EX-10.12    Material Contract                                   HTML     49K 
13: EX-10.13    Material Contract                                   HTML    105K 
14: EX-10.14    Material Contract                                   HTML     44K 
15: EX-10.15    Material Contract                                   HTML     44K 
16: EX-10.16    Material Contract                                   HTML     49K 
17: EX-10.17    Material Contract                                   HTML    102K 
18: EX-10.18    Material Contract                                   HTML     51K 
19: EX-10.19    Material Contract                                   HTML     45K 
 5: EX-10.2     Material Contract                                   HTML     15K 
20: EX-10.20    Material Contract                                   HTML     45K 
21: EX-10.21    Material Contract                                   HTML    177K 
22: EX-10.22    Material Contract                                   HTML    123K 
 6: EX-10.3     Material Contract                                   HTML    114K 
 7: EX-10.7     Material Contract                                   HTML    102K 
 8: EX-10.8     Material Contract                                   HTML     59K 
 9: EX-10.9     Material Contract                                   HTML     57K 
23: EX-21.1     Subsidiaries                                        HTML     10K 
24: EX-23.1     Consent of Experts or Counsel                       HTML      9K 
25: EX-99.2     Miscellaneous Exhibit                               HTML     29K 
26: EX-99.3     Miscellaneous Exhibit                               HTML     11K 


EX-10.11   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




Exhibit 10.11

 

Rights and Obligations Assignment Agreement

 

This Rights and Obligations Assignment Agreement (this “Agreement”) is made in Shanghai as of July 13, 2017 by and among:

 

(1)             Jing LIU, a citizen of the People’s Republic of China (“PRC”) whose ID number is ******************;

 

(2)             Shuhong YUAN, Chinese Citizen, ID No.: ******************;

 

(3)             Yue XUAN, Chinese Citizen, ID No.: ******************;

 

(4)             YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD., a wholly foreign-owned enterprise organized and existing under the laws of the PRC with its legal address at Room 805, Suite B, No.1 Building, No.977, Shangfeng Road, Tang Town, Pudong New Area, Shanghai, China (“WFOE”); and

 

(5)             GUANGDONG YIHAO PHARMACY CO., LTD., a limited liability company organized and existing under the laws of the PRC with its legal address at Zone A, 2/F, No.1 Gonghe Road (West), Yuexiu District, Guangzhou, China (“Operating Company”)

 

(The abovementioned parties hereinafter referred to collectively as the “Parties” and each a “Party”).

 

WHEREAS:

 

1.                  WFOE, Yue XUAN and Shuhong YUAN entered into the Exclusive Option Agreement in respect of GUANGDONG YIHAO PHARMACY CO., LTD. on September 5, 2013, Yue XUAN, Shuhong YUAN, WFOE and the Operating Company entered into the Proxy Agreement on September 5, 2013, and WFOE, Yue XUAN and Shuhong YUAN entered into the Proxy Agreement in respect of GUANGDONG YIHAO PHARMACY CO., LTD. on September 5, 2013 (collectively, “Original Agreements”).

 

2.                  Jing LIU, Yue XUAN and Shuhong YUAN entered into the Equity Transfer Agreement on July 13, 2017, pursuant to which Shuhong YUAN has transferred all of the shares held by her in the Operating Company to Jing LIU.

 

3.                  Shuhong YUAN wishes to assign all of her rights and obligations under the Original Agreements to Jing LIU, and Jing LIU agrees to accept the assignment of all of Shuhong YUAN’s rights and obligations under the Original Agreements.

 

THEREFORE, it is agreed as follows:

 

1.                  As of the effective date of this Agreement (“Effective Date”), Shuhong YUAN shall assign all of her rights, interests, obligations and liabilities under the Original Agreements to Jing LIU (“Assignment of Rights and Obligations”).

 

2.                  Jing LIU hereby agrees to accept the Assignment of Rights and Obligations, and to fully perform and comply with the Original Agreements and exercise all of the rights and perform all of the obligations of Shuhong YUAN under the Original Agreement from the Effective Date.

 

3.                  Yue XUAN, WFOE and the Operating Company hereby agree on the Assignment of Rights and Obligations and Jing LIU succeeds Shuhong YUAN as a party to the Original Agreement from the Effective Date.

 

4.                  This Agreement shall be governed by and interpreted in accordance with the laws of the PRC.

 

5.                  Any dispute arising from or in connection with this Agreement shall be submitted to the Shanghai International Economic and Trade Arbitration Commission (“Commission”) to be settled through

 



 

arbitration in accordance with the then effective arbitration rules of the Commission. The arbitration award shall be final and binding on both Parties.

 

6.                  This Agreement shall take effect from the date on which it is signed (applicable to a natural person) or signed and sealed (applicable to a legal entity) by the Parties hereto.

 

7.                  This Agreement shall be made in quintuplicate counterparts, with each party holding one counterpart with equal legal effect.

 

[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK; THE SIGNATURE PAGE IS ATTACHED HEREINBELOW]

 



 

IN WITNESS WHEREOF, the Parties have executed this Rights and Obligations Assignment Agreement on the date first written above.

 

Jing LIU

Shuhong YUAN

 

 

Signature:

/s/ Jing LIU

 

Signature:

/s/ Shuhong YUAN

 

 

Yue XUAN

YAO FANG INFORMATION TECHNOLOGY (SHANGHAI) CO., LTD.

 

 

 

Legal Representative:

 

 

 

 

Signature:

/s/ Meijuan GAO

 

 

 

 

 

Signature:

/s/ Yue XUAN

 

Seal:

/s/ Seal of Yao Fang Information Technology (Shanghai) Co., Ltd.

 

 

 

 

 

 

GUANGDONG YIHAO PHARMACY CO., LTD.

 

 

 

Legal Representative: 

 

 

 

 

 

Signature:

/s/ Du ZOU

 

 

 

 

 

Seal:

/s/ Seal of Guangdong Yihao Pharmacy Co., Ltd.

 

 




Dates Referenced Herein

This ‘F-1’ Filing    Date    Other Filings
Filed on:8/15/18None on these Dates
7/13/17
9/5/13
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/28/23  111, Inc.                         20-F       12/31/22  109:13M                                    Toppan Merrill/FA
 4/29/22  111, Inc.                         20-F       12/31/21  110:14M                                    Toppan Merrill/FA
 4/30/21  111, Inc.                         20-F       12/31/20  119:15M                                    Toppan Merrill/FA
 9/05/18  SEC                               UPLOAD10/11/18    2:138K 111, Inc.
Top
Filing Submission 0001047469-18-005629   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 7:06:01.2pm ET